Presently, Samira Sakhia occupies the position of President, Chief Executive Officer & Director at Knight Therapeutics, Inc. and Chairman for Biotoscana Investments SA (a subsidiary of Knight Therapeutics, Inc.) and Secretary, Director & Vice President at Labopharm USA, Inc.

She is also on the board of Dollarama, Inc., McGill University Health Center and Montreal Society For The Prevention of Cruelty To Animals and Member-Governors Board at McGill University.

In her past career she held the position of Independent Director at Antibe Therapeutics, Inc., CFO & Head-Investor Relations at Paladin Labs, Inc., Controller-North American Operations at Discreet Logic, Inc. and Auditor of Arthur Andersen LLP.

Samira Sakhia received an undergraduate degree and an MBA from McGill University.